Viewing Study NCT02666261


Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-01-27 @ 3:23 AM
Study NCT ID: NCT02666261
Status: COMPLETED
Last Update Posted: 2019-03-21
First Post: 2016-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module